The Future of Account-Based Selling

*By submitting your information to our website you agree to the terms outlined in our privacy policy.

The B2B sales landscape has dramatically changed in the last ten years. What will the future hold as B2B sales continues evolving?  How can you ensure your sales organization is ahead of the curve?

Learn how account-based selling (ABS) can position your sales team for sustained success and result in increased revenue from new and existing accounts.

• Trends and insights driving the future of B2B sales

• Ways sales and marketing teams should align to penetrate ever-expanding buying groups

• Ideas for aligning account insights to succeed in increasingly competitive markets

• How Account-Based Sales technology solutions support organizations in the new world

• Why a revenue operations function will no longer be an option

Attend this webinar and learn how to empower your reps with an account-based sales approach.

Join Revegy and guest speaker Seth Marrs, Principal Analyst at Forrester, on September 15th to learn:

Seth Marrs
Forrester, Principal Analyst

September 15th, 2021 @ 2 pm EST | 11 am PST

Seth has more than 20 years of experience leading sales operations, service operations, and marketing organizations. He excels at leveraging data, process, and technology to drive growth in organizations of all sizes and in all industries.

Previous Work Experience
Before joining Forrester, Seth spent the last five years as a consultant and senior vice president leading sales operations and marketing organizations for multiple private equity-backed companies ranging in size from $200 million to $1 billion, where he was responsible for customer acquisition, sales execution, and compensation.

Before going into private equity, Seth led sales operations for Carl Zeiss Meditec in the United States and held multiple executive sales and service roles at GE Healthcare, including leading sales operations for GE Life Sciences EMEA, building and running a global lean organization for the $3 billion life sciences division of GE Healthcare, and leading sales enablement for the US region (which represented $7 billion of GE Healthcare’s revenue).